CSF2 and psoriasis: Moreover, the challenge of EVES with a disease-relevant psoriasis cocktail identified elevated secretion of disease-specific markers, including TSLP, IL-22, Granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-17, all of which could be attenuated by the IKK2 inhibitor.